SCHEMBL1331248

SCHEMBL1331248

O=C(Cl)/C=C/c1cccc(C(F)(F)F)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HB P07237 2/20 0.62
MEN1 O00255 1/20 0.62
LMNA P02545 1/20 0.62
HSP90AA1 P07900 1/20 0.62
MAPT P10636 1/20 0.62
PKM P14618 1/20 0.62
KMT2A Q03164 1/20 0.62
NPSR1 Q6W5P4 1/20 0.62
MAOB P27338 5/20 0.59
L3MBTL1 Q9Y468 2/20 0.57
HTT P42858 1/20 0.57
THRB P10828 1/20 0.57
MAOA P21397 1/20 0.57
KDM4E B2RXH2 1/20 0.56
FBP1 P09467 1/20 0.54
NFE2L2 Q16236 1/20 0.53
CA12 O43570 1/20 0.52
CA1 P00915 1/20 0.52
CA2 P00918 1/20 0.52
CA9 Q16790 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30932120 1.00 P4HB (0.62) P4HBMEN1LMNAHSP90AA1MAPT
SCHEMBL1331250 1.00 P4HB (0.62) P4HBMEN1LMNAHSP90AA1MAPT
SCHEMBL12002074 0.86 P4HB (0.66) P4HBMEN1LMNAHSP90AA1MAPT
SCHEMBL17061419 0.86 P4HB (0.66) P4HBMEN1LMNAHSP90AA1MAPT
SCHEMBL80207 0.85 NPSR1 (0.64) P4HBMEN1LMNAHSP90AA1MAPT
SCHEMBL29426408 0.85 NPSR1 (0.64) P4HBMEN1LMNAHSP90AA1MAPT
SCHEMBL15673342 0.85 NPSR1 (0.64) P4HBMEN1LMNAHSP90AA1MAPT
SCHEMBL80208 0.85 NPSR1 (0.64) P4HBMEN1LMNAHSP90AA1MAPT
SCHEMBL11799529 0.83 L3MBTL1 (0.64) P4HBMEN1LMNAHSP90AA1MAPT
SCHEMBL1405103 0.83 L3MBTL1 (0.64) P4HBMEN1LMNAHSP90AA1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 196 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115458724-B High-energy-density composite positive electrode material and preparation method and application thereof 中国科学院深圳先进技术研究院 2025-03-25 CN claimed
CN-115594771-B Modified cellulose derivative, method for producing same, moisture-sensitive material composition, and moisture-sensitive film 广州奥松电子股份有限公司 2023-08-11 CN claimed
CN-115594771-A Modified cellulose derivative, method for producing same, moisture-sensitive material composition, and moisture-sensitive film 广州奥松电子股份有限公司(CN) 2023-01-13 CN claimed
CN-115458724-A High-energy-density composite cathode material and preparation method and application thereof 中国科学院深圳先进技术研究院 2022-12-09 CN claimed
EP-4421851-B1 RESIN, INSULATING FILM AND ORGANIC FIELD EFFECT TRANSISTOR COMPRISING SAME TOSOH CORP (JP) 2026-04-22 EP disclosed
CN-115458724-B High-energy-density composite positive electrode material and preparation method and application thereof 中国科学院深圳先进技术研究院 2025-03-25 CN disclosed
US-20240425620-A1 RESIN, INSULATING FILM AND ORGANIC FIELD EFFECT TRANSISTOR COMPRISING SAME TOSOH CORPORATION (JP) 2024-12-26 US disclosed
EP-4421851-A1 RESIN, INSULATING FILM AND ORGANIC FIELD EFFECT TRANSISTOR COMPRISING SAME Tosoh Corporation (JP) 2024-08-28 EP disclosed
CN-118160078-A Resin, insulating film, and organic field effect transistor device including the same 东曹株式会社 2024-06-07 CN disclosed
CN-114230519-B Pleuromutilin cinnamate compounds with drug-resistant bacteria resisting activity, and synthetic method and application thereof 西咸新区沣厚原创医药科技有限公司 2024-06-04 CN disclosed
US-11872202-B2 Pleuromutilin cinnamic acid ester compounds with activities against antibiotic-resistant infections SHAANXI UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2024-01-16 US disclosed
CN-115594771-B Modified cellulose derivative, method for producing same, moisture-sensitive material composition, and moisture-sensitive film 广州奥松电子股份有限公司 2023-08-11 CN disclosed
EP-0661283-A1 BRAIN CELL PROTECTIVE TORAY INDUSTRIES, INC. (JP) 1995-07-05 EP disclosed
WO-1994022823-A1 4-ARYLISOINDOLE ANALGESICS ORTHO PHARMACEUTICAL CORPORATION (US) 1994-10-13 WO disclosed
EP-0577847-A1 MORPHINAN DERIVATIVE AND MEDICINAL USE TORAY INDUSTRIES, INC. (JP) 1994-01-12 EP disclosed
EP-0332387-B1 Triazole derivatives, their preparation and their use as fungicides SANKYO CO (JP) 1993-11-24 EP disclosed
EP-0332387-A1 Triazole derivatives, their preparation and their use as fungicides Sankyo Company Limited (JP) 1989-09-13 EP disclosed
US-4410696-A Antitumor and immunosuppressive 4-carbamoylimidazolium-5-olate derivatives SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1983-10-18 US disclosed
EP-0075629-A1 Imidazole derivatives, their preparation, and their pharmaceutical compositions Sumitomo Chemical Industries Ltd. (JP) 1983-04-06 EP disclosed
US-4151303-A Phenoxyalkylcarboxylic acid compounds and serum-lipid and triglyceride depressing therapeutic compositions BOEHRINGER MANNHEIM GMBH (DE) 1979-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11872202-B2 Pleuromutilin cinnamic acid ester compounds with activities against antibiotic-resistant infections RELA, PLEC, ABL1 P4HB 420/4885MEN1 244/4885LMNA 1674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.